DK453488D0 - Fremgangsmaade til fremstilling af en lamineret opbygning inden i en lukket beholder - Google Patents

Fremgangsmaade til fremstilling af en lamineret opbygning inden i en lukket beholder

Info

Publication number
DK453488D0
DK453488D0 DK453488A DK453488A DK453488D0 DK 453488 D0 DK453488 D0 DK 453488D0 DK 453488 A DK453488 A DK 453488A DK 453488 A DK453488 A DK 453488A DK 453488 D0 DK453488 D0 DK 453488D0
Authority
DK
Denmark
Prior art keywords
subunits
preparing
procedure
dispersions
melt
Prior art date
Application number
DK453488A
Other languages
English (en)
Other versions
DK453488A (da
DK175797B1 (da
Inventor
Patricia S Campbell
David J Enscore
Robert M Gale
Arnold Kaufman
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22189156&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK453488(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of DK453488D0 publication Critical patent/DK453488D0/da
Publication of DK453488A publication Critical patent/DK453488A/da
Application granted granted Critical
Publication of DK175797B1 publication Critical patent/DK175797B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Laminated Bodies (AREA)
  • Colloid Chemistry (AREA)
  • Lining Or Joining Of Plastics Or The Like (AREA)
  • Liquid Crystal Substances (AREA)
DK198804534A 1987-08-13 1988-08-12 Fremgangsmåde til fremstilling af en lamineret opbygning inden i en lukket beholder DK175797B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/085,052 US4832953A (en) 1987-08-13 1987-08-13 Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
US8505287 1987-08-13

Publications (3)

Publication Number Publication Date
DK453488D0 true DK453488D0 (da) 1988-08-12
DK453488A DK453488A (da) 1989-02-14
DK175797B1 DK175797B1 (da) 2005-02-28

Family

ID=22189156

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198804534A DK175797B1 (da) 1987-08-13 1988-08-12 Fremgangsmåde til fremstilling af en lamineret opbygning inden i en lukket beholder

Country Status (14)

Country Link
US (1) US4832953A (da)
EP (1) EP0304227B1 (da)
JP (1) JP2610314B2 (da)
KR (1) KR910000411B1 (da)
AT (1) ATE86126T1 (da)
AU (1) AU600634B2 (da)
CA (1) CA1331340C (da)
DE (1) DE3878781T2 (da)
DK (1) DK175797B1 (da)
ES (1) ES2042754T3 (da)
GR (1) GR3008020T3 (da)
IE (1) IE61680B1 (da)
NZ (1) NZ225766A (da)
PT (1) PT88269B (da)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308621A (en) * 1991-02-18 1994-05-03 Commonwealth Scientific And Industrial Research Organisation Ascorbic acid composition and transdermal administration method
US5827245A (en) * 1992-07-16 1998-10-27 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising the active subtance 17-β-Estradiol (Anhydrous)
DE4223360C1 (da) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
AU3512595A (en) * 1994-09-13 1996-03-29 Magainin Pharmaceuticals, Inc. Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
US5662928A (en) * 1995-04-21 1997-09-02 Ciba-Geigy Corporation Method for the prevention or removal of crystalline scopolamine in a non-aqueous matrix of a transdermal system
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
US6238700B1 (en) * 1995-12-01 2001-05-29 Alza Corporation Method for preventing crystal formation in a dispersion of a liquid in a matrix
ATE207348T1 (de) * 1995-12-01 2001-11-15 Alza Corp Verbessertes verfahren zur verhinderung der kristallbildung in einer dispersion eines flüssigen stoffes in einer matrix
ATE226816T1 (de) * 1996-07-03 2002-11-15 Alza Corp Vorrichtungen zur arzneistoffabgabe und herstellungsverfahren
US6007837A (en) * 1996-07-03 1999-12-28 Alza Corporation Drug delivery devices and process of manufacture
KR100483913B1 (ko) * 1996-07-03 2005-09-02 알자 코포레이션 약물송달장치
US6174545B1 (en) 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
DE19738643C2 (de) * 1997-09-04 2001-10-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
US6918901B1 (en) * 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
EP1911488A3 (en) 1997-12-11 2008-12-03 Alza Corporation Device for enhancing transdermal agent flux
CN1170603C (zh) * 1997-12-11 2004-10-13 阿尔扎有限公司 增强透皮物剂流量的装置
CN1206004C (zh) 1997-12-11 2005-06-15 阿尔扎有限公司 增强透皮物剂流量的装置
KR100572539B1 (ko) * 1997-12-11 2006-04-24 알자 코포레이션 경피성 작용제 유동률을 증진시키기 위한 장치
PT1041975E (pt) 1997-12-22 2003-01-31 Alza Corp Membranas de controlo de taxa para dispositivos de fornecimento controlado de drogas
JP2002525172A (ja) * 1998-09-29 2002-08-13 ザース・インコーポレーテッド 薬剤活性化合物の改良された適用方法及び装置
US20070196490A1 (en) * 1999-01-22 2007-08-23 Powderject Research Limited Method of enhancing needleless transdermal powered drug delivery
DK1239916T3 (da) 1999-12-10 2006-04-03 Alza Corp Indretning og fremgangsmåde til at forbedre perforering af hud med mikrofremspring
ATE355854T1 (de) * 2000-08-03 2007-03-15 Antares Pharma Ipl Ag Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
EP1670433B1 (en) * 2003-10-10 2011-11-23 Antares Pharma IPL AG Transdermal pharmaceutical formulation for minimizing skin residues
US7387788B1 (en) 2003-10-10 2008-06-17 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
WO2007124250A2 (en) * 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2006125642A1 (en) * 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
KR100699582B1 (ko) 2005-07-11 2007-03-23 삼성전기주식회사 출력 버퍼회로
CA2618468A1 (en) * 2005-08-12 2007-02-22 Astrazeneca Ab Process for the preparation of a stable dispersion of sub-micron particles in an aqueous medium
US7888422B2 (en) 2005-11-09 2011-02-15 Mylan Technologies Inc. Long-wearing removable pressure sensitive adhesive
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
EP2425894B1 (en) 2007-06-21 2016-12-28 Gen-Probe Incorporated Instruments and method for exposing a receptacle to multiple thermal zones
US9017301B2 (en) * 2007-09-04 2015-04-28 Mylan Technologies, Inc. Transdermal drug delivery systems comprising a coated release liner
CA2726136C (en) * 2008-05-30 2016-11-01 Mylan Laboratories, Inc. Stabilized transdermal drug delivery system
US20100086582A1 (en) * 2008-10-06 2010-04-08 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
JP5648174B2 (ja) 2009-05-04 2015-01-07 ヌボ リサーチ インコーポレイテッド 神経腫、神経絞扼、および他の状態と関連する疼痛を処置する方法
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
DE102009052972A1 (de) 2009-11-12 2011-09-15 Lts Lohmann Therapie-Systeme Ag Verfahren zur Verhinderung der Kristallisation von Arzneistoffen in einem Polymerfilm
JP5766475B2 (ja) 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
WO2011135532A2 (en) 2010-04-28 2011-11-03 Kimberly-Clark Worldwide, Inc. Composite microneedle array including nanostructures thereon
MX2012012567A (es) 2010-04-28 2012-11-21 Kimberly Clark Co Metodo para aumentar la permeabilidad de una barrera epitelial.
KR101794376B1 (ko) 2010-04-28 2017-11-06 킴벌리-클라크 월드와이드, 인크. ｓｉＲＮＡ 전달용 의료 기구
EP2563450B1 (en) 2010-04-28 2017-07-26 Kimberly-Clark Worldwide, Inc. Device for delivery of rheumatoid arthritis medication
US8696637B2 (en) 2011-02-28 2014-04-15 Kimberly-Clark Worldwide Transdermal patch containing microneedles
CA2790749A1 (en) * 2011-09-29 2013-03-29 Nitto Denko Corporation Manufacturing method of patch preparation
EP3574950B1 (en) 2011-10-27 2021-02-17 Sorrento Therapeutics, Inc. Transdermal delivery of high viscosity bioactive agents
JP5270035B1 (ja) * 2012-12-06 2013-08-21 久光製薬株式会社 貼付剤及びその製造方法
JP5307931B1 (ja) 2012-12-27 2013-10-02 久光製薬株式会社 貼付剤及びその製造方法
JP5415645B1 (ja) 2013-06-28 2014-02-12 久光製薬株式会社 貼付剤の製造方法、貼付剤及び包装体
DE102018120506A1 (de) * 2017-10-20 2019-04-25 Amw Gmbh Stabilisiertes transdermales Darreichungssystem
CN113677343B (zh) * 2019-03-19 2023-11-24 耐贝医药株式会社 生物体对药物的吸收性优异且化学稳定性也优异的医药组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4436741A (en) * 1975-12-08 1984-03-13 Alza Corporation Method for administering scopolamine transdermally
US4262003A (en) * 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
US4230105A (en) * 1978-11-13 1980-10-28 Merck & Co., Inc. Transdermal delivery of drugs
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
US4532244A (en) * 1984-09-06 1985-07-30 Innes Margaret N Method of treating migraine headaches
JPH0742228B2 (ja) * 1985-11-13 1995-05-10 日東電工株式会社 医薬製剤

Also Published As

Publication number Publication date
PT88269B (pt) 1996-01-31
JP2610314B2 (ja) 1997-05-14
KR910000411B1 (ko) 1991-01-25
PT88269A (pt) 1989-06-30
IE882424L (en) 1989-02-13
DK453488A (da) 1989-02-14
GR3008020T3 (da) 1993-09-30
DK175797B1 (da) 2005-02-28
EP0304227A3 (en) 1989-06-28
KR890003354A (ko) 1989-04-14
AU2060788A (en) 1989-02-16
EP0304227A2 (en) 1989-02-22
DE3878781T2 (de) 1993-06-09
DE3878781D1 (de) 1993-04-08
IE61680B1 (en) 1994-11-16
NZ225766A (en) 1990-06-26
CA1331340C (en) 1994-08-09
AU600634B2 (en) 1990-08-16
US4832953A (en) 1989-05-23
ES2042754T3 (es) 1993-12-16
ATE86126T1 (de) 1993-03-15
EP0304227B1 (en) 1993-03-03
JPS6466113A (en) 1989-03-13

Similar Documents

Publication Publication Date Title
DK453488A (da) Fremgangsmaade til fremstilling af en lamineret opbygning inden i en lukket beholder
ES403104A1 (es) Un metodo de fabricacion de un material ceramico.
Rodrigues et al. Isothermal and non-isothermal crystallization of a fresnoite glass
GB949233A (en) A fusion process for producing a compound or an alloy in crystalline form
Tang et al. Growth of a new UV nonlinear optical crystal:: KBe2 (BO3) F2
Morrison et al. The growth of large single-crystal Bi4Ti3O12
US5343827A (en) Method for crystal growth of beta barium boratean
Fujimori et al. Calorimetric study of 1, 3-diphenyl-1, 1, 3, 3-tetramethyldisiloxane: Emergence of α-, β-, and crystalline-glass transitions
GB923241A (en) A method of and an apparatus for growing crystals in a vessel of vitreous material
EP0022193B1 (en) Improved process for growing crystal of ktiopo4 and analogues thereof
EP1022772A4 (en) CdTe CRYSTAL OR CdZnTe CRYSTAL AND PREPARATION METHOD
Kima et al. Growth of lithium triborate crystals by the TSSG technique
US2803519A (en) Method of preparing barium titanate
EP0187843B1 (en) Growth of single crystal cadmium-indium-telluride
JPH07309691A (ja) 結晶の製造方法及び製造装置
EP0132954A2 (en) Liquid phase growth of crystalline polyphosphide
Ivleva et al. Growth and ferroelectric properties of Nd-doped strontium–barium niobate crystals
JPS6236095A (ja) 有機薄膜結晶の作成方法
Laudise et al. Organo-thermal crystal growth of α6 thiophene
JP2739547B2 (ja) 硼酸リチウム単結晶の製造方法
KR100320586B1 (ko) 고압 결정성장장치
KR890005825A (ko) 덴드라이트 웨브 실리콘 결정성장 방법
JPH0489385A (ja) 化合物単結晶の育成方法
JPH02279583A (ja) 単結晶育成方法
张金平 et al. CRYSTALLOGRAPHIC PARAMETERS AND HEAT PROPERTIES OF 3BaO· 3B_2O_3· 2GeO_2

Legal Events

Date Code Title Description
PUP Patent expired